D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$454M |
| 2 |
Apple
AAPL
|
+$364M |
| 3 |
Procter & Gamble
PG
|
+$314M |
| 4 |
Verizon
VZ
|
+$308M |
| 5 |
Pfizer
PFE
|
+$299M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$735M |
| 2 |
Emerson Electric
EMR
|
+$423M |
| 3 |
Biogen
BIIB
|
+$354M |
| 4 |
PayPal
PYPL
|
+$349M |
| 5 |
Amazon
AMZN
|
+$338M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.77% |
| 2 | Healthcare | 11.58% |
| 3 | Consumer Discretionary | 8.97% |
| 4 | Financials | 7.64% |
| 5 | Communication Services | 5.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2926
PUT
Revolve Group
RVLV
$1.79B
| $691K | ﹤0.01% |
+80,000
| New | +$1.27M |
|
|
VIA
2927
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
| $691K | ﹤0.01% |
22,051
-16,018
| -42% | -$703K |
|
|
FOCS
2928
CALL
DELISTED
Focus Financial Partners Inc. Class A
FOCS
| $690K | ﹤0.01% |
+30,000
| New | +$796K |
|
2929
PUT
OSI Systems
OSIS
$3.57B
| $689K | ﹤0.01% |
+10,000
| New | +$855K |
|
|
CSLT
2930
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $686K | ﹤0.01% |
949,116
-166,965
| -15% | -$186K |
|
2931
PUT
NETGEAR
NTGR
$669M
| $685K | ﹤0.01% |
+30,000
| New | +$674K |
|
2932
PUT
Targa Resources
TRGP
$60.4B
| $685K | ﹤0.01% |
+99,100
| New | +$2.95M |
|
2933
Monro
MNRO
$525M
| $684K | ﹤0.01% |
15,618
-16,269
| -51% | -$986K |
|
|
SHYF
2934
DELISTED
The Shyft Group
SHYF
| $684K | ﹤0.01% |
52,976
-163,384
| -76% | -$2.58M |
|
2935
10x Genomics
TXG
$5.87B
| $684K | ﹤0.01% |
10,973
+6,970
| +174% | +$544K |
|
2936
Northwest Natural Holdings
NWN
$2.17B
| $683K | ﹤0.01% |
11,067
+6,026
| +120% | +$421K |
|
|
AAN.A
2937
PUT
DELISTED
The Aaron's Company Inc Class A
AAN.A
| $683K | ﹤0.01% |
+30,000
| New | +$683K |
|
2938
PUT
Thomson Reuters
TRI
$39.4B
| $679K | ﹤0.01% |
+9,491
| New | +$739K |
|
2939
Addus HomeCare
ADUS
$2.14B
| $676K | ﹤0.01% |
9,998
+5,034
| +101% | +$435K |
|
2940
PUT
Chegg
CHGG
$108M
| $676K | ﹤0.01% |
18,900
| – | – |
|
2941
CALL
Five Below
FIVE
$11.2B
| $676K | ﹤0.01% |
9,600
-131,500
| -93% | -$13.4M |
|
2942
Movado Group
MOV
$812M
| $674K | ﹤0.01% |
56,982
+46,495
| +443% | +$734K |
|
2943
ANI Pharmaceuticals
ANIP
$1.77B
| $673K | ﹤0.01% |
16,523
-20,482
| -55% | -$1.09M |
|
2944
PUT
Genuine Parts
GPC
$17.1B
| $673K | ﹤0.01% |
10,000
-22,700
| -69% | -$2.02M |
|
2945
CALL
NovoCure
NVCR
$2.04B
| $673K | ﹤0.01% |
10,000
| – | – |
|
2946
PUT
Credicorp
BAP
$30.9B
| $672K | ﹤0.01% |
+4,700
| New | +$889K |
|
|
USCR
2947
DELISTED
U S Concrete, Inc.
USCR
| $672K | ﹤0.01% |
+37,048
| New | +$1.14M |
|
|
BFYT
2948
CALL
DELISTED
Benefytt Technologies, Inc. Class A Common Stock
BFYT
| $672K | ﹤0.01% |
+30,000
| New | +$712K |
|
|
GNMK
2949
DELISTED
GenMark Diagnostics, Inc
GNMK
| $670K | ﹤0.01% |
162,762
-474,397
| -74% | -$2.22M |
|
2950
Capital Southwest
CSWC
$1.46B
| $666K | ﹤0.01% |
+58,276
| New | +$1.05M |
|
Similar funds
D.E. Shaw & Co's Q1 2020 Portfolio in Review
As of Q1 2020, D.E. Shaw & Co held 4,498 positions worth $64.1B, down 27% from $87.5B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
D.E. Shaw & Co withdrew a net $5.59B in Q1 2020, closing 626 positions and reducing 1,723 holdings. Its most notable exit was PG&E, an estimated $79M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, D.E. Shaw & Co opened a new position in iShares iBoxx $ Investment Grade Corporate Bond ETF worth $124M.
- D.E. Shaw & Co's largest Q1 2020 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 1,005,000 shares worth $124M.
- D.E. Shaw & Co added most to ExxonMobil in Q1 2020, an estimated $454M increase.
- D.E. Shaw & Co's biggest Q1 2020 reduction was Tesla, cutting an estimated $735M.
- D.E. Shaw & Co fully exited PG&E in Q1 2020, selling an estimated $79M.
- D.E. Shaw & Co's ten largest holdings make up 12% of its $64.1B portfolio in Q1 2020.
- D.E. Shaw & Co opened 538 new positions and closed 626 in Q1 2020.
- D.E. Shaw & Co's portfolio value fell 27% quarter-over-quarter to $64.1B.
Based on D.E. Shaw & Co's 13F filing for Q1 2020, filed 15 May 2020.